[Toxoplasma encephalitis].
Yamamoto T.
Nihon Naika Gakkai Zasshi. 2006 Jul 10;95(7):1260-2. doi: 10.2169/naika.95.1260.
Cerebral toxoplasmosis in HIV-infected patients: a review.
Dian S, Ganiem AR, Ekawardhani S.
Pathog Glob Health. 2023 Feb;117(1):14-23. doi: 10.1080/20477724.2022.2083977. Epub 2022 Jun 11.
HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
Vidal JE.
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. doi: 10.1177/2325958219867315.
Central nervous system infection with Toxoplasma gondii.
Marra CM.
Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8.
Toxoplasmosis.
Lynfield R, Guerina NG.
Pediatr Rev. 1997 Mar;18(3):75-83. doi: 10.1542/pir.18-3-75.
Animal Models for Toxoplasma gondii Infection.
S Subauste C, Hubal A.
Curr Protoc. 2023 Sep;3(9):e871. doi: 10.1002/cpz1.871.
Image Diagnosis: Eccentric Target Sign of Focal Toxoplasma Encephalitis.
Verma S, Singla V, Singh A, Bose A, Pannu AK.
Perm J. 2020;24:19.181. doi: 10.7812/TPP/19.181. Epub 2020 Apr 22.
A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
Almurshidi BH, Fahmy Z, El-Shennawy A, Selim EAH, Hammam OA, Okasha H, Al-Hajj W, Mahmoud SA, Abuelenain GL.
Parasite Immunol. 2023 Dec;45(12):e13014. doi: 10.1111/pim.13014. Epub 2023 Oct 9.
Immunopathogenesis of toxoplasmic encephalitis.
Hunter CA, Remington JS.
J Infect Dis. 1994 Nov;170(5):1057-67. doi: 10.1093/infdis/170.5.1057.
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B.
Medicine (Baltimore). 1992 Jul;71(4):224-39. doi: 10.1097/00005792-199207000-00005.
